LB
60
4
CVS
52
-6
MRK
35
2
AVY
54
-4
AMZN
59
3
OI
38
-5
HPQ
66
6
KO
47
-2
AEE
64
3
TSCO
48
-3
RL
80
2
HCA
48
2
JWN
59
2
BBY
42
2
VNO
68
3
CMS
64
4
ADBE
61
11
FLR
56
-2
SNA
65
-3
SLG
64
-2
LB
60
4
CVS
52
-6
MRK
35
2
AVY
54
-4
AMZN
59
3
OI
38
-5
HPQ
66
6
KO
47
-2
AEE
64
3
TSCO
48
-3
RL
80
2
HCA
48
2
JWN
59
2
BBY
42
2
VNO
68
3
CMS
64
4
ADBE
61
11
FLR
56
-2
SNA
65
-3
SLG
64
-2
Financhill
Back

Cue Biopharma Stock Price Chart

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28

CUE
Cue Biopharma

Last Price:
1.23
Seasonality Move:
14.02%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CUE is experiencing slight buying pressure.

Cue Biopharma Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 1.09 Buy
20-day SMA: 1.42 Sell
50-day SMA: 1.2 Sell
200-day SMA: 1.36 Sell
8-day EMA: 1.15 Sell
20-day EMA: 1.29 Sell
50-day EMA: 1.23 Sell
200-day EMA: 1.44 Sell

Cue Biopharma Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 40.82 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.18 - 1.74) Sell
Bollinger Bands (100): (0.57 - 1.35) Buy

Cue Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Cue Biopharma Stock

Is Cue Biopharma Stock a Buy?

  • Cue Biopharma share price is 1.09 while CUE 8-day simple moving average is 1.09, which is a Buy signal.
  • The stock price of CUE is 1.09 while Cue Biopharma 20-day SMA is 1.42, which makes it a Sell.
  • Cue Biopharma 50-day simple moving average is 1.20 while CUE share price is 1.09, making it a Sell technically.
  • CUE stock price is 1.09 and Cue Biopharma 200-day simple moving average is 1.36, creating a Sell signal.

CUE Technical Analysis vs Fundamental Analysis

Sell
28
Cue Biopharma (CUE) is a Sell

Is Cue Biopharma a Buy or a Sell?

  • Cue Biopharma stock is rated a Sell
    The current Cue Biopharma [CUE] share price is $1.09. The Score for CUE is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.

Cue Biopharma Stock Info

Market Cap:
69.05M
Price in USD:
1.09
Share Volume:
507.89K

Cue Biopharma 52-Week Range

52-Week High:
3.25
52-Week Low:
0.45
Sell
28
Cue Biopharma (CUE) is a Sell

Cue Biopharma Share Price Forecast

  • What is the Cue Biopharma stock price today?
    The Cue Biopharma stock price is 1.09 USD today.
  • Will CUE stock go up or go down?
    Cue Biopharma> share price is forecast to RISE/FALL based on technical indicators
  • Is Cue Biopharma overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cue Biopharma is overvalued.

Is Cue Biopharma Stock a Buy?

  • Cue Biopharma share price is 1.09 while CUE 8-day exponential moving average is 1.15, which is a Sell signal.
  • The stock price of CUE is 1.09 while Cue Biopharma 20-day EMA is 1.29, which makes it a Sell.
  • Cue Biopharma 50-day exponential moving average is 1.23 while CUE share price is 1.09, making it a Sell technically.
  • CUE stock price is 1.09 and Cue Biopharma 200-day simple moving average is 1.44, creating a Sell signal.

Fundamental Analysis of Cue Biopharma

Is Cue Biopharma a good investment?

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.19 per share.

Technical Analysis of Cue Biopharma

Should I short Cue Biopharma stock?

* Cue Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.